Clinical and Laboratory Measurements in Diabetic Neuropathies

  • Sanjeev Kelkar


This chapter deals with Peripheral Somatosensory Neuropathies, its anatomy in brief, clinical manifestations, and laboratory diagnosis of the same. Technically, Motor Peripheral Neuropathies are also result from the same type of thick myelinated fibers, but their profile and investigation is quite different from the Sensory Nerves. Hence these are discussed in a separate chapter. Similar is the case with Small fiber Neuropathies; hence these are also discussed separately. Sensory disturbances are commoner and more easily manifest, describable by the patients. Hence the separate treatment which also avoids long details which may confuse the subject maters. Occasionally references are made to autonomic nerves which essentially fall in small fiber neuropathies. Autonomic Nerve pathologies and related issue are described in separate chapters.



Neuropathy Symptom Score


Neuropathy Disability Score


Neuropathy Impairment Score


Neuropathy Symptom Profile


Neuropathy Symptoms and Change Score are the common generic scores. The other names are given below, of which many relate to the Institutions which have brought these about and validated


  1. 1.
    Korean Diabetes Association. Treatment guideline for diabetes. J Korean Diabetes. 2015;12:S109–12.Google Scholar
  2. 2.
    Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, et al. Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Clin Pract. 2014;103:522–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Won JC, Kwon HS, Kim CH, Lee JH, Park TS, Ko KS, et al. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with type 2 diabetes in Korea. Diabet Med. 2012;29:e290–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Chawla A, Bhasin G, Chawla R. Validation of neuropathy symptoms score (NSS) and neuropathy disability score (NDS) in the clinical diagnosis of peripheral neuropathy in middle aged people with diabetes. Int J Fam Pract. 2013;12(1):1–4.Google Scholar
  5. 5.
    Asad A, Hameed MA, Khan UA, Butt MU, Ahmed N, Nadeem A. Comparison of nerve conduction studies with diabetic neuropathy symptom score and diabetic neuropathy examination score in type-2 diabetics for detection of sensorimotor polyneuropathy. J Pak Med Assoc. 2009;59(9):594–8.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Afifi L, Abdelalim AM, Ashour AS, Al-Athwari A. Correlation between clinical neuropathy scores and nerve conduction studies in patients with diabetic peripheral neuropathy. Egypt J Neurol Psychiatry Neurosurg. 2016;53(4):248.CrossRefGoogle Scholar
  7. 7.
    Kamel SR, Hamdy M, Omar HA, Kamal A, Ali LH, Elkarim AH. Clinical diagnosis of distal diabetic polyneuropathy using neurological examination scores: correlation with nerve conduction studies. Egypt Rheumatol Rehabil. 2015;42(3):128.CrossRefGoogle Scholar
  8. 8.
    Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150–4.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, et al. The north-west diabetes foot care study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377–84.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Papanas N, Papatheodorou K, Papazoglou D, Kotsiou S, Maltezos E. A prospective study on the use of the indicator test Neuropad(R) for the early diagnosis of peripheral neuropathy in type 2 diabetes. Exp Clin Endocrinol Diabetes. 2011;119(2):122–5.PubMedCrossRefGoogle Scholar
  11. 11.
    Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O’Brien PC, Service FJ. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care. 1987;10(4):432–40.PubMedCrossRefGoogle Scholar
  12. 12.
    Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve. 1988;11(1):21–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Perkins BA, Bril V. Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol. 2003;114(7):1167–75.PubMedCrossRefGoogle Scholar
  14. 14.
    Meijer JW, Smit AJ, Sonderen EV, Groothoff JW, Eisma WH, Links TP. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the diabetic neuropathy symptom score. Diabet Med. 2002;19(11):962–5.PubMedCrossRefGoogle Scholar
  15. 15.
    Dyck PJ, Davies JL, Litchy WJ, O’Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester diabetic neuropathy study cohort. Neurology. 1997;49(1):229–39.PubMedCrossRefGoogle Scholar
  16. 16.
    van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155:654–62.PubMedCrossRefGoogle Scholar
  17. 17.
    Bennett M. The LANSS pain scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001;92:147–57. [PubMed: 11323136]PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136:380–7. [PubMed: 17888574]PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Venkataramana AB, Skolasky RL, Creighton JA, et al. Diagnostic utility of the subjective peripheral neuropathy screen in HIV-infected persons with peripheral sensory polyneuropathy. AIDS Read. 2005;15:341–4.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Spallone V, Morganti R, D’Amato C, et al. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012;29:578–85.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the neuropathic pain symptom inventory. Pain. 2004;108:248–57.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11:89–95.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Singleton JR, Bixby B, Russell JW, Feldman EL, Peltier A, Goldstein J, Howard J, Smith AG. The Utah early neuropathy scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst. 2008;13:218–27. PubMed: 18844788.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Sharma S, Kerry C, Atkins H, Rayman G. The Ipswich touch test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Diabet Med. 2014;31(9):1100–3.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Saltzman CL, Rashid R, Hayes A, Fellner C, Fitzpatrick D, Klapach A, Frantz R, Hillis SL. 4.5-gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients. J Bone Joint Surg Am. 2004;86:717–23.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Miranda-Palma B, Sosenko JM, Bowker JH, Mizel MS, Boulton AJM. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract. 2005;70:8–12.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Bril V, Perkins BA. Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies. Diabet Med. 2002;19(8):661–6.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17(6):557–60.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Willits I, Cole H, Jones R, Dimmock P, Arber M, Craig J, Sims A. VibraTip for testing vibration perception to detect diabetic peripheral neuropathy: a NICE medical technology guidance. Appl Health Econ Health Policy. 2015;13:315.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Bowling FL, Abbott CA, Harris WE, Atanasov S, Malik RA, Boulton AJ. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting. Diabet Med. 2012;29(12):1550–2.PubMedCrossRefGoogle Scholar
  31. 31.
    Ponirakis G, Odriozola MN, Odriozola S, et al. NerveCheck: an inexpensive quantitative sensory testing device for patients with diabetic neuropathy. Diabetes Res Clin Pract. 2016;113:101–7.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Haanpaa M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152:14–27.PubMedCrossRefGoogle Scholar
  33. 33.
    Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158(3):289–92.PubMedCrossRefGoogle Scholar
  34. 34.
    Vinik AI, Suwanwalaikorn S, Stansberry KB, et al. Quantitative measurement of cutaneous perception in diabetic neuropathy. Muscle Nerve. 1995;18:574–84.PubMedCrossRefGoogle Scholar
  35. 35.
    Bril V, Vinik AI, Litchy WJ, for the MBBQ Study Group, et al. Detectable sural nerve action potential (SNAP) identifies patients with early diabetic peripheral neuropathy (DPN). Diabetes. 2002;51(Suppl 2):A197.Google Scholar
  36. 36.
    Steiness I. Vibratory perception in normal subjects: a biothesiometric study. Acta Med Scand. 1957;158:315–25.PubMedCrossRefGoogle Scholar
  37. 37.
    Malik RA, Newrick PG, Sharma AK, et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia. 1989;32:92–102.PubMedCrossRefGoogle Scholar
  38. 38.
    Giannini C, Dyck PJ. Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol. 1995;3995(37):498–504.CrossRefGoogle Scholar
  39. 39.
    Resnick HE, Vinik AI, Schwartz AV, et al. Independent effects of peripheral nerve dysfunction on lower- extremity physical function in old age: the Women's health and aging study. Diabetes Care. 2000;23:1642–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Menz HB, Lord SR, St George R, Fitzpatrick RC. Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. Arch Phys Med Rehabil. 2004;85:245–52.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27:1458–86.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Coppini DV, Young PJ, Weng C, et al. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study. Diabet Med. 1998;15:765–71.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Russell JW, Karnes JL, Dyck PJ. Sural nerve myelinated fiber density differences associated with meaningful changes in clinical and electrophysiologic measurements. J Neurol Sci. 1996;135:114–7.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Sanjeev Kelkar
    • 1
  1. 1.Independent Health ResearcherPuneIndia

Personalised recommendations